Home / Stocks / Gpt Healthcare Limited
GPTHEALTH

Gpt Healthcare Limited Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹132.45

Change

-2.05 (-1.52%)

Open

₹136.0

Prev. Close

₹134.5

Day High

₹136.75

Day Low

₹132.01

Volume Analysis

Traded

72,443

Delivered

44,439

Delivery %

61.34%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (2)

  • •Strong return on equity (28.5%)
  • •Strong operating margin (22.0%)

Weaknesses (0)

No signal for this stock

Opportunities (0)

No signal for this stock

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹140.21 ₹138.48 ₹135.47 ₹133.74 ₹130.73 ₹129.0 ₹125.99
Fibonacci ₹138.48 ₹136.67 ₹135.55 ₹133.74 ₹131.93 ₹130.81 ₹129.0
Camarilla ₹133.75 ₹133.32 ₹132.88 ₹133.74 ₹132.02 ₹131.58 ₹131.15

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-5.52%

1 Week

-8.69%

1 Month

-2.38%

3 Months

-12.08%

6 Months

-5.39%

1 Year

-7.58%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

DuPont ROE Breakdown

26.44%

Net margin 12.46% × asset turnover 1.04x × equity multiplier 2.04x

Company Overview

Sector

Healthcare

Market Cap

₹1,136 Cr

P/E (TTM)

27.3

ROE

28.5%

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.

TopFund Analysis

Gpt Healthcare Limited holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 65/100. The strongest factor is Cash Flow (99/100), while Institutional Ownership (17/100) is the weakest area to weigh before deciding. Notably: Strong return on equity (28.5%); strong operating margin (22.0%). FII holding has been falling.

TopFund Score — Fundamentals Quality

65/100 — Good

Data confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

82

Valuation

59

Cash Flow

99

Corporate Governance

56

Momentum

39

Institutional Ownership

17

Business Quality

88

Risk & Volatility

64

Liquidity

42

From Screener.in

  • +Company has reduced debt.
  • +Company has been maintaining a healthy dividend payout of 53.9%

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Audio recording of investor call on Q2 and H1 FY2026-27 unaudited results uploaded.

Copies of the News Paper publication on Un-Audited Financial Results for Q2 & H1 FY 27 and Notice of Record Date.

GPT Healthcare reported H1 FY27 income of Rs 266.8 crore, PAT Rs 28.1 crore, up 53.9%.

Investor Presentation on Un-Audited Financial Results for the Q2 & H1 FY27.

Source: BSE regulatory filings, via Screener.in.

Profit & Loss (Yearly)

  Mar 2020 Mar 2021 Mar 2022
Sales + 212 243 337
Expenses + 176 194 263
Operating Profit 36 49 74
OPM % 17.0% 20.0% 22.0%
Other Income + 4 6 5
Interest 14 14 11
Depreciation 11 12 14
Profit before tax 15 29 54
Tax % 26.0% 27.0% 23.0%
Net Profit + 11 21 42
EPS in Rs 1 3 5
Dividend Payout % 0.0% 47.0% 115.0%
Sales growth — 15 39

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2020 Mar 2021 Mar 2022
Reserves 109 116 78
Borrowings + 157 163 96
Other Liabilities + 25 20 70
Total Liabilities 308 317 323
Fixed Assets + 226 220 220
CWIP 2 0 1
Investments 1 1 10
Other Assets + 80 97 92
Total Assets 308 317 323
Equity Capital 18 18 80

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2020 Mar 2021 Mar 2022
Cash from Operating Activity + 41 43 66
Cash from Investing Activity + -54 -16 -5
Cash from Financing Activity + 12 -22 -57
Net Cash Flow -1 4 3
Free Cash Flow -5 38 59
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 116 82 107

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 65.57% → 65.57%
  Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 16.14% 17.16% 18.92% 18.41% 18.59% 20.14% 24.77% 25.48% 24.79% 24.46% 24.32%
Promoters 65.57% 65.57% 65.57% 65.57% 65.57% 65.57% 65.57% 65.57% 65.57% 65.57% 65.57%
FII 6.68% 5.38% 4.7% 4.71% 4.49% 4.96% 3.2% 2.73% 2.81% 3.03% 3.01%
DII 11.61% 11.88% 10.8% 11.3% 11.35% 9.33% 6.45% 6.2% 6.84% 6.94% 7.1%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Gpt Healthcare Limited (this stock) 1,136 27.3 — 28.5%
Bafna Pharmaceuticals Ltd 1,121 — 2.19 -6.18%
3b Blackbio Dx Ltd. 1,157 19.7 3.33 19.8%
Sigachi Industries Ltd 1,088 41.3 2.02 5.78%
Laxmi Dental Limited 1,076 29.7 4.05 14.8%
Lincoln Pharma Ltd 1,032 10.6 1.27 12.0%
Gujarat Kidney N Sup Sp L 1,269 66.8 4.82 11.1%

Which Mutual Funds Hold Gpt Healthcare Limited?

Frequently Asked Questions about Gpt Healthcare Limited

Community Sentiment

What are other investors saying about Gpt Healthcare Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.